Monoamine Oxidase: Radiotracer Development and Human Studies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (136)
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
1983 • 4,822 citations
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
1983 • 3,439 citations
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
1965 • 3,421 citations
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
1997 • 2,394 citations
Abnormal Behavior Associated with a Point Mutation in the Structural Gene for Monoamine Oxidase A
1993 • 1,620 citations
Some observations upon a new inhibitor of monoamine oxidase in brain tissue
1968 • 1,589 citations
Aggressive Behavior and Altered Amounts of Brain Serotonin and Norepinephrine in Mice Lacking MAOA
1995 • 1,211 citations
Smoking, Smoking Cessation, and Major Depression
1990 • 1,174 citations
MONOAMINE OXIDASE: From Genes to Behavior
1999 • 1,154 citations
Prevalence of smoking among psychiatric outpatients
1986 • 1,059 citations
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
1984 • 1,007 citations
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
1989 • 913 citations
cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.
1988 • 713 citations
Neocortical cell counts in normal human adult aging
1987 • 676 citations
Inhibition of monoamine oxidase B in the brains of smokers
1996 • 666 citations
Ginkgo Biloba
1996 • 622 citations
The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
1989 • 621 citations
Pargyline Prevents MPTP-Induced Parkinsonism in Primates
1984 • 575 citations
Some puzzling pharmacological effects of monoamine oxidase inhibitors.
1972 • 561 citations
Ginkgo biloba
1992 • 451 citations
Suicide substrates: mechanism-based enzyme inactivators
1982 • 443 citations
Brain monoamine oxidase A inhibition in cigarette smokers
1996 • 427 citations
Mapping Human Brain Monoamine Oxidase A and B with 11 C-Labeled Suicide Inactivators and PET
1987 • 388 citations
Cigarette smoking and protection from Parkinson's disease
1995 • 372 citations
Suicide enzyme inactivators
1976 • 366 citations
Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography
1994 • 361 citations
Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem
1988 • 347 citations
The effect of age on the activity and molecular properties of human brain monoamine oxidase
1980 • 342 citations
Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19- 6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain
1992 • 332 citations
Relation of Sex and Aging to Monoamine Oxidase Activity of Human Brain, Plasma, and Platelets
1971 • 288 citations
Tyramine oxidase
1928 • 276 citations
Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type
1980 • 254 citations
Increased stress response and β–phenylethylamine in MAOB–deficient mice
1997 • 254 citations
Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐Deprenyl
1986 • 243 citations
Involvement of tobacco in alcoholism and illicit drug use
1990 • 239 citations
Age-Related Increases in Brain Monoamine Oxidase B in Living Healthy Human Subjects
1997 • 238 citations
Smoking and Parkinson’s disease
1999 • 222 citations
AMINE OXIDASES
1955 • 183 citations
Relationship between cigarette smoking and Alzheimer's disease in a population‐based case‐control study
1993 • 179 citations
Monoamine neurons in aging and Alzheimer's disease
1993 • 175 citations
Über den enzymatischen Abbau von Histamin und Diaminen. 2. Mitteilung
1938 • 168 citations
A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*
1995 • 167 citations
Monoamine oxidase, brain ageing and degenerative diseases
1989 • 155 citations
Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping.
1995 • 155 citations
Monoamine oxidase inhibitors and the cheese effect
1993 • 150 citations
The inactivation of adrenaline
1937 • 149 citations
Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawal
1994 • 146 citations
Monoamine oxidase A and B activities in heavy smokers
1995 • 140 citations
Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition
1993 • 140 citations
Low platelet monoamine oxidase activity in cigarette smokers
1981 • 130 citations
Expression of monoamine oxidase B activity in astrocytes of senile plaques
1990 • 128 citations
Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo
1996 • 127 citations
Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using <scp>l</scp>‐[11C]Deprenyl
1987 • 119 citations
The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavine of mitochondrial amine oxidase
1976 • 119 citations
TREATMENT OF PULMONARY TUBERCULOSIS WITH HYDRAZIDE DERIVATIVES OF ISONICOTINIC ACID
1952 • 119 citations
Dopaminergic system and monoamine oxidase-B Activity in Alzheimer's disease
1988 • 116 citations
Extracts of ginkgo biloba leaves inhibit monoamine oxidase
1996 • 112 citations
Differential age-related changes of mao-a and mao-b in mouse brain and pe peripheral organs
1994 • 109 citations
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327
1991 • 105 citations
Monoamine Oxidase and Mitochondrial Respiration
1999 • 105 citations
Effects of endogenous dopamine on measures of [18F]N‐methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons
1991 • 105 citations
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation
2003 • 104 citations
Effect of lazabemide on the progression of disability in early Parkinson's disease
1996 • 104 citations
Mechanistic Positron Emission Tomography Studies: Demonstration of a Deuterium Isotope Effect in the Monoamine Oxidase‐Catalyzed Binding of [11C]l‐Deprenyl in Living Baboon Brain
1988 • 103 citations
Therapeutic Value of Ginkgo biloba in Reducing Symptoms of Decline in Mental Function
1999 • 101 citations
THE PSYCHIATRIC SIDE-EFFECTS OF IPRONIAZID
1956 • 99 citations
Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco Leaves
1999 • 98 citations
DEUTERIUM ISOTOPE EFFECTS IN RELATION TO THE CHEMICAL MECHANISM OF MONOAMINE OXIDASE*
1963 • 95 citations
The molecular pharmacology of L-deprenyl
1992 • 95 citations
Localization of monoamine oxidases in human peripheral tissues
1996 • 95 citations
Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors
1985 • 92 citations
Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease
1993 • 83 citations
Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
1999 • 80 citations
11C-harmine as a tracer for monoamine oxidase a (MAO-A): In vitro and in vivo studies
1997 • 75 citations
Hidden persuasion
1996 • 74 citations
Platelet monoamine oxidase activity and psychopathy
1985 • 74 citations
Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes
1992 • 73 citations
Platelet monoamine oxidase: Low activity in cigarette smokers
1987 • 70 citations
Measurement of Cerebral Monoamine Oxidase B Activity Using L-[11C]Deprenyl and Dynamic Positron Emission Tomography
1991 • 69 citations
Maintenance of Brain Monoamine Oxidase B Inhibition in Smokers After Overnight Cigarette Abstinence
2000 • 68 citations
Monoamine oxidases: old friends hold many surprises
1995 • 65 citations
Potential Metabolic Bioactivation Pathways Involving Cyclic Tertiary Amines and Azaarenes
1997 • 65 citations
Synthesis of suicide inhibitors of monoamine oxidase: Carbon‐11 labeled clorgyline, L‐deprenyl and D‐deprenyl
1988 • 65 citations
Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: Potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography
1985 • 64 citations
Characterization of phentermine and related compounds as monoamine oxidase (mao) inhibitors
2000 • 60 citations
Synthesis of some 11C-labelled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain
1997 • 58 citations
Monoamine oxidases and related amine oxidases as phase I enzymes in the metabolism of xenobiotics
1998 • 57 citations
Positron Emission Tomography with [11C]Deuterium‐Deprenyl in Temporal Lobe Epilepsy
1995 • 57 citations
THE DRAMBALLET STUDIO
1996 • 54 citations
Plasma input function determination for PET using a commercial laboratory robot
1995 • 53 citations
Treatment of Negative Symptoms in Schizophrenia and Schizoaffective Disorder by Selegiline Augmentation of Antipsychotic Medication
1996 • 52 citations
Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition
1993 • 52 citations
In Vitro Quantitative Autoradiography of [3H]‐L‐Deprenyl and [3H]‐PK 11195 Binding Sites in Human Epileptic Hippocampus
1992 • 52 citations
Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers
1999 • 49 citations
MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography
1997 • 47 citations
Monoamine oxidase, dopamine and Parkinson's disease
1991 • 45 citations
Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain
2000 • 43 citations
Selegiline Effects on Cocaine-Induced Changes in Medial Temporal Lobe Metabolism and Subjective Ratings of Euphoria
1999 • 43 citations
Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex
1995 • 43 citations
An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo
1998 • 41 citations
Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl, (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and PET studies in baboon brain
1990 • 40 citations
Non‐MAO A binding of clorgyline in white matter in human brain
2001 • 34 citations
Schizophrenia, Monoamine Oxidase Activity, and Cigarette Smoking
1999 • 32 citations
PET imaging of monoamine oxidase B in peripheral organs in humans.
2002 • 31 citations
Mechanistic Positron Emission Tomography Studies of 6‐[18F]Fluorodopamine in Living Baboon Heart: Selective Imaging and Control of Radiotracer Metabolism Using the Deuterium Isotope Effect
1995 • 30 citations
Radioactive N,N‐Dimethylphenylethylamine: A Selective Radiotracer for In Vivo Measurement of Monoamine Oxidase‐B Activity in the Brain
1985 • 30 citations
Species differences in [ 11 C]clorgyline binding in brain
2001 • 29 citations
Synthesis and in vivo studies of a specific monoamine oxidase B inhibitor: 5-[4-(benzyloxy)phenyl]-3-(2-cyanoethyl)-1,3,4-oxadiazol-[11C]-2(3H)-one
1996 • 29 citations
Evidence that Ginkgo biloba extract does not inhibit MAO A and B in living human brain
2000 • 29 citations
Sensitivity of [11C]phenylephrine kinetics to monoamine oxidase activity in normal human heart.
1999 • 29 citations
Biodistribution of a positron-emitting suicide inactivator of monoamine oxidase, carbon-11 pargyline, in mice and a rabbit.
1985 • 28 citations
Kinetics of [11C]N,N-dimethylphenylethylamine in mice and humans: potential for measurement of brain MAO-B activity.
1987 • 27 citations
Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice
1999 • 26 citations
Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiology
1998 • 25 citations
Evidence that l-deprenyl treatment for one week does not inhibit mao a or the dopamine transporter in the human brain
2001 • 23 citations
Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies
1992 • 23 citations
Deprenyl prolongs the therapeutic efficacy of combined L-DOPA in Parkinson's disease.
1984 • 22 citations
11C-labelling of dimethylphenethylamine in two different positions and biodistribution studies
1989 • 21 citations
The in vitro insertion of monoamine oxidase B into mitochondrial outer membranes
1988 • 20 citations
Monoamine oxidase B single-photon emission tomography with [ 123 I]Ro 43-0463: imaging in volunteers and patients with temporal lobe epilepsy
1998 • 17 citations
Catecholamines and Blood Pressure Regulation
1990 • 17 citations
In Vivo properties of N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamide 18F- and 123I-labelled reversible inhibitors of monoamine oxidase B
1998 • 16 citations
MAO-A ENZYME BINDING IN BLADDER-CANCER CHARACTERIZED WITH [C-11] HARMINE IN FROZEN-SECTION AUTORADIOGRAPHY
1995 • 16 citations
Development of N-[3-(2′,4′-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A
1999 • 13 citations
Comparison of Brain Glucose Metabolism and Monoamine Oxidase B (MAO B) in Traumatic Brain Injury
1999 • 13 citations
Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A
1996 • 12 citations
Evaluation of a Ginkgo biloba Extract (EGb 761) in Functional Tests for Monoamine Oxidase Inhibition
2011 • 11 citations
Evaluation of radioiodinated iodoclorgyline as a SPECT radiopharmaceutical for MAO-A in the brain
1995 • 11 citations
[13N]-β-phenethylamine ([13N]PEA): A prototype tracer for measurement of MAO-B activity in heart
1987 • 11 citations
[] N-(2-aminoethyl)-5-halogeno-2-pyridinecarbox-amides, site specific tracers for MAO-B mapping with SPET and PET
1995 • 10 citations
Deuterium isotope effect of [ 11 C 1 ]N, N-dimethylphenethyl-amine-α, α-d 2 ; reduction in metabolic trapping rate in brain
1986 • 10 citations
Iododerivative of pargyline: A potential tracer for the exploration of monoamine oxidase sites by SPECT
1995 • 9 citations
An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration
1996 • 7 citations
123I-labeling and evaluation of Ro 43–0463, a spet tracer for MAO-B imaging
1995 • 7 citations
Selegiline HC1: Selective MAO-type B inhibitor.
1990 • 5 citations
Deleted Work
1955 • 0 citations